Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
| Autor: | Barsotti AM; Oncology Research Unit, Pfizer Worldwide Research & Development, Pearl River, NY 10965, USA.; Kadmon Pharmaceuticals, New York, NY 10016, USA., Ryskin M; Oncology Research Unit, Pfizer Worldwide Research & Development, Pearl River, NY 10965, USA., Rollins RA; Oncology Research Unit, Pfizer Worldwide Research & Development, Pearl River, NY 10965, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Epigenomics [Epigenomics] 2015 Aug; Vol. 7 (5), pp. 687-90. Date of Electronic Publication: 2015 Aug 28. |
| DOI: | 10.2217/epi.15.27 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|